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Objective: Intestinal inflammation is associated with enhanced mucosal hypoxia, which 
contributes to the ongoing inflammatory process and hampers appropriate mucosal healing. 
We questioned whether local treatment with an oxygen-carrying and -releasing molecule 
(oxygenated perfluorodecalin, O2-PFD) could positively influence the course of experimental 
colitis. 
Design: The impact of intrarectal treatment with O2-PFD was tested using the murine dextran 
sodium sulfate (DSS)-induced model of distal colitis, both in preventive and therapeutic 
settings. Colonic mucosal hypoxia was visualized by pimonidazole-staining. Colonic 
permeability was evaluated with FITC-dextran. 
Results: In the preventive study, mice treated with O2-PFD were protected against DSS colitis 
compared to saline-treated mice, as demonstrated by reduced shortening of colon length, 
reduced colonic TNF-α levels and a lower histological inflammation score (P<0.05 for all 
parameters). In the therapeutic study, administration of O2-PFD resulted in accelerated 
recovery of colitis compared to saline-treated littermates, and this was reflected by a better 
weight evolution, lower myeloperoxidase activity and a lower histological inflammation score 
(P<0.05 for all parameters). 
It was found that O2-PFD established its therapeutic effects through (i) intrinsic anti-
inflammatory effects of the PFD molecule and (ii) O2-induced preservation and healing of the 
intestinal epithelial surface. Further in vitro and in vivo studies showed that the barrier-
protective activity of O2-PFD was obtained through prevention of colonocyte apoptosis and 
stimulation of colonocyte proliferation during inflammatory hypoxia. 
Conclusions: These data show that intrarectal treatment with oxygenated PFD promotes 
colitis healing by the combined actions of direct anti-inflammatory effects and O2-induced 
restitution of the epithelial barrier. As such, O2-PFD enemas could be an attractive treatment 
option for patients with distal IBD. 
